You are here: Home » News-CM » Companies » Results
Business Standard

Marksans Pharma consolidated net profit rises 19.54% in the December 2019 quarter

Capital Market 

Sales rise 15.82% to Rs 287.65 crore

Net profit of Marksans Pharma rose 19.54% to Rs 29.18 crore in the quarter ended December 2019 as against Rs 24.41 crore during the previous quarter ended December 2018. Sales rose 15.82% to Rs 287.65 crore in the quarter ended December 2019 as against Rs 248.37 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales287.65248.37 16 OPM %16.4414.57 -PBDT45.6634.59 32 PBT38.3429.55 30 NP29.1824.41 20

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, February 11 2020. 15:11 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU